Cargando…
Drug-Repositioning Approaches Based on Medical and Life Science Databases
Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is redu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591243/ https://www.ncbi.nlm.nih.gov/pubmed/34790124 http://dx.doi.org/10.3389/fphar.2021.752174 |
_version_ | 1784599184425353216 |
---|---|
author | Zamami, Yoshito Hamano, Hirofumi Niimura, Takahiro Aizawa, Fuka Yagi, Kenta Goda, Mitsuhiro Izawa-Ishizawa, Yuki Ishizawa, Keisuke |
author_facet | Zamami, Yoshito Hamano, Hirofumi Niimura, Takahiro Aizawa, Fuka Yagi, Kenta Goda, Mitsuhiro Izawa-Ishizawa, Yuki Ishizawa, Keisuke |
author_sort | Zamami, Yoshito |
collection | PubMed |
description | Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases. |
format | Online Article Text |
id | pubmed-8591243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85912432021-11-16 Drug-Repositioning Approaches Based on Medical and Life Science Databases Zamami, Yoshito Hamano, Hirofumi Niimura, Takahiro Aizawa, Fuka Yagi, Kenta Goda, Mitsuhiro Izawa-Ishizawa, Yuki Ishizawa, Keisuke Front Pharmacol Pharmacology Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases. Frontiers Media S.A. 2021-11-01 /pmc/articles/PMC8591243/ /pubmed/34790124 http://dx.doi.org/10.3389/fphar.2021.752174 Text en Copyright © 2021 Zamami, Hamano, Niimura, Aizawa, Yagi, Goda, Izawa-Ishizawa and Ishizawa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zamami, Yoshito Hamano, Hirofumi Niimura, Takahiro Aizawa, Fuka Yagi, Kenta Goda, Mitsuhiro Izawa-Ishizawa, Yuki Ishizawa, Keisuke Drug-Repositioning Approaches Based on Medical and Life Science Databases |
title | Drug-Repositioning Approaches Based on Medical and Life Science Databases |
title_full | Drug-Repositioning Approaches Based on Medical and Life Science Databases |
title_fullStr | Drug-Repositioning Approaches Based on Medical and Life Science Databases |
title_full_unstemmed | Drug-Repositioning Approaches Based on Medical and Life Science Databases |
title_short | Drug-Repositioning Approaches Based on Medical and Life Science Databases |
title_sort | drug-repositioning approaches based on medical and life science databases |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591243/ https://www.ncbi.nlm.nih.gov/pubmed/34790124 http://dx.doi.org/10.3389/fphar.2021.752174 |
work_keys_str_mv | AT zamamiyoshito drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT hamanohirofumi drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT niimuratakahiro drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT aizawafuka drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT yagikenta drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT godamitsuhiro drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT izawaishizawayuki drugrepositioningapproachesbasedonmedicalandlifesciencedatabases AT ishizawakeisuke drugrepositioningapproachesbasedonmedicalandlifesciencedatabases |